维普中文期刊产品整合服务
15篇 您的检索式:作者名="Pettay JD"
    题名 作者 年代 出处 被引量
1Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy:apparent immunohistochemical false-positives do not get the message显示文摘Tubbs RR Pettay JD Roche PC 2001J Clin Oncol2001,19,10:1
2显示文摘 Pettay JD Tvakhi A 1997Hematopathology1997,107,:1
3Tissue microarrays: A powerful tool for high-throughput analysis of clinical specimens: A review of the method with validation data显示文摘Skacel M Skilton B Pettay JD 2002Appl Immunohistochem Mol Morphol2002,10,1:1
4Diffuse large B-cell lymphoma of the stomach:assessment of microsatellite instability,allelic imbalance,and tresomy of chromosomes 3,12,and 18显示文摘 Paris PL Pettay JD 2002Diagn Mol Pathol2002,11,2:1
5Tissue microarrays:apowerful tool for high-throughput analysis of clinical specimens:a review of the method with validation data显示文摘Skacel M Skilton B Pettay JD 2002Appl Immuno-histochem Mol Morphol2002,10,1:1
6Risk factors for trisomy 21 : maternal cigarette smoking and oral contraceptive use in a population - based case control study显示文摘Yang Q Sherman SL Hassold TJ Allran K Taft LF Pettay D Khoury MJ Erickson JD Freeman SB 1999Genet Med1999,1,:1
7Tissue microarrays : apowerful tool for high- throughput analysis of clinical specimens: a review of the method with validation data 显示文摘Skacel M Skilton B Pettay JD 2002Appl Immunohistochem Mol Morphol2002,10,1:1
8Tissue microarray: a powerful tool for high-throughput analysis of clinical specimens 显示文摘SKACEL M SKILTON B PETTAY JD 2002Appl Immunohistochem Mol Morphol2002,10,1:1
9Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message 显示文摘TUBBS RR PETTAY JD ROCHE PC 2001J Clin Oncol2001,19,10:1
10Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message显示文摘Tubbs RR Pettay JD Roche PC 2001J Clin 0ncol2001,19,10:1
11Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message 显示文摘Tubbs RR Pettay JD Roche PC 2001J Clin Oncol2001,19,10:1
12Tissue microarrays:a powerful tool for hlgh-throughput analysis of clinical specimens:a review of the method with validation data显示文摘Skacel M Skihon B Pettay JD 2002Immunohistochem Mol Morphol2002,10,2:1
13Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy:apparent immunohistochemical false-positives do not get the message显示文摘Tubbs RR Pettay JD Roche PC 2001J Clin Oncol2001,19,10:1
14Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message显示文摘Tubbs RR Pettay JD Roche PC 2001J Clin Oncol2001,19,10:1
15Tissue microarrays:a powerful tool for high-throughput analysis of clinical specimens:a review of the method with validation data显示文摘Skacel M Skilton B Pettay JD 0,,01:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费